Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Yun, Jihye, Rago, Carlo, Cheong, Ian, Pagliarini, Ray, Angenendt, Philipp, Rajagopalan, Harith, Schmidt, Kerstin, Willson, James K. V., Markowitz, Sandy, Zhou, Shibin, Diaz, Luis A., Velculescu, Victor E., Lengauer, Christoph, Kinzler, Kenneth W., Vogelstein, Bert, Papadopoulos, Nickolas·2009·Science
Cited by (910)
Items 401–500 of 910
- DUSP6 regulates drug sensitivity by modulating DNA damage responseTetyana Bagnyukova, Diana Restifo, Neil Beeharry, Linara Gabitova, Tai Li, Ilya G. Serebriiskii, Erica A. Golemis, Igor A. Astsaturov · 2013 · British Journal of Cancer
- DNA Damage–Induced Modulation of GLUT3 Expression Is Mediated through p53-Independent Extracellular Signal-Regulated Kinase Signaling in HeLa CellsMasaru Watanabe, Hiroaki Naraba, Tomoko Sakyo, Takayuki Kitagawa · 2010 · Molecular Cancer Research
- KRAS Mutation Dictates the Cancer Immune Environment in Pancreatic Ductal Adenocarcinoma and Other AdenocarcinomasGu, Meichen, Gao, Yanli, Chang, Pengyu · 2021 · Cancers
- Molecular Pathways: Regulation of Metabolism by RBBrian F. Clem, Jason Alan Chesney · 2012 · Clinical Cancer Research
- GLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinaseRoger J. Liang, Samuel R. Taylor, Navid Nahiyaan, Junho Song, Charles J. Murphy, Ezequiel Dantas, Shuyuan Cheng, Ting-Wei Hsu, Shakti Ramsamooj, Rahul Grover et al. · 2021 · Cancer & Metabolism
- Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients.Dimitrios Krikelis, Evangelia V. Skoura, Vassiliki Kotoula, Phivi Rondogianni, Nikoletta K. Pianou, Alexandros P. Samartzis, Ioannis Xanthakis, George Fountzilas, Ioannis Datseris · 2014 · PubMed
- GRP78 is implicated in the modulation of tumor aerobic glycolysis by promoting autophagic degradation of IKKβZongwei Li, Yingying Wang, Ian P. Newton, Lichao Zhang, Pengyu Ji, Zhuoyu Li · 2015 · Cellular Signalling
- 18F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243Edwin Chang, Hongguang Liu, Kerstin Unterschemmann, Peter Ellinghaus, Shuanglong Liu, Volker Gekeler, Zhen Cheng, Dietmar Berndorff, Sanjiv Sam Gambhir · 2014 · Clinical Cancer Research
- Targeting Glucose Transporter 1 (GLUT1) in Cancer: Molecular Mechanisms and Nanomedicine ApplicationsZhen Ren, Jingyuan Zhao, Shuai Li, Hong Yuan · 2025 · International Journal of Nanomedicine
- KRAS and BRAF Mutation Analysis in Colorectal Adenocarcinoma Specimens with a Low Percentage of Tumor CellsMarzena Anna Lewandowska, Wojciech Jóźwicki, Bogdan A. Żurawski · 2013 · Molecular Diagnosis & Therapy
- Determination of glucose in human stomach cancer cell extracts and single cells by capillary electrophoresis with a micro-biosensorXiaolei Wang, Yanfang Ma, Man Zhao, Minfeng Zhou, Yan Xiao, Zifei Sun, Lili Tong · 2016 · Journal of Chromatography A
- KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancerYong‐Hee Cho, Pu-Hyeon Cha, Saluja Kaduwal, Jong-Chan Park, Sang Gyu Lee, Jeong-Soo Yoon, Wookjin Shin, Hyuntae Kim, Eun Ji Ro, Kyung-Hwa Koo et al. · 2016 · Oncotarget
- Reconciling environment-mediated metabolic heterogeneity with the oncogene-driven cancer paradigm in precision oncologyCatherine Vander Linden, Cyril Corbet · 2019 · Seminars in Cell and Developmental Biology
- Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic CancerRachel L. Dittmar, Suyu Liu, Mei-Chee Tai, Kimal Rajapakshe, Ying Huang, Gary Longton, Christine DeCapite, Mark W. Hurd, Pamela L. Paris, Kimberly Saunders Kirkwood et al. · 2021 · Cancer Prevention Research
- The hexosamine biosynthesis pathway and O‐Glc NA cylation maintain insulin‐stimulated PI 3K‐ PKB phosphorylation and tumour cell growth after short‐term glucose deprivationDavid R. Jones, Willem‐Jan Keune, Karen E. Anderson, Len Stephens, Phillip T. Hawkins, Nullin Divecha · 2014 · FEBS Journal
- Glucose-dependent glucose transporter 1 expression and its impact on viability of thyroid cancer cellsPaweł Jóźwiak, Anna Krześlak, Magdalena Bryś, Anna Lipińska · 2014 · Oncology Reports
- Targeting metabolic reprogramming as a potential therapeutic strategy in melanomaLorey K. Smith, Aparna Dodla Rao, Grant A. McArthur · 2016 · Pharmacological Research
- Isoform-specific Ras signaling is growth factor dependentFiona E. Hood, Bertram Klinger, Anna U. Newlaczyl, Anja Sieber, Mathurin Dorel, Simon P. Oliver, Judy M. Coulson, Nils Blüthgen, Ian A. Prior · 2019 · Molecular Biology of the Cell
- Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancerKnickelbein, Kyle, Tong, Jingshan, Chen, Dongshi, Wang, Yi-Jun, Misale, Sandra, Bardelli, Alberto, Yu, Jian, Zhang, Lin · 2018 · Oncogene
- microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancerHidekazu Takahashi, Masanobu Takahashi, Shinobu Ohnuma, Michiaki Unno, Yuki Yoshino, Kota Ouchi, Shinʼ ichi Takahashi, Yasuhide Yamada, Hideki Shimodaira, Chikashi Ishioka · 2017 · BMC Cancer
- The induction of HAD-like phosphatases by multiple signaling pathways confers resistance to the metabolic inhibitor 2-deoxyglucoseQuentin Defenouillère, Agathe Verraes, Clotilde Laussel, Anne Friedrich, Joseph Schacherer, Sébastien Léon A · 2019 · Science Signaling
- A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular CarcinomaHua Yang, Mu-Zi-he Zhang, Huiwei Sun, Yantao Chai, Xiaojuan Li, Qiyu Jiang, Jun Hou · 2021 · Frontiers in Oncology
- Cancer biology in diabetesSen Shi, Yanzheng He, Daisuke Koya, Keizo Kanasaki · 2014 · Journal of Diabetes Investigation
- Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancerDebarshi Roy, Susmita Mondal, Chen Wang, Xiaoping He, Ashwani Khurana, Shailendra Giri, Robert G. Hoffmann, Deok‐Beom Jung, Sung H Kim, Eduardo N. Chini et al. · 2014 · Cancer & Metabolism
- Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cellsMarijke C.C. Sachweh, William C. Stafford, Catherine J. Drummond, Anna R. McCarthy, Maureen Higgins, Johanna Campbell, Bertha A. Brodin, Elias S.J. Arnér, Sonia Laı́n · 2015 · Oncotarget
- Determination of glucose deficiency-induced cell death by mitochondrial ATP generation-driven proton homeostasisYanfen Cui, Yuanyuan Wang, Miao Liu, Li Qiu, Pan Xing, Xin Wang, Guoguang Ying, Binghui Li · 2017 · Journal of Molecular Cell Biology
- Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal AdenocarcinomaZiying Jian, Tao Cheng, Zhiheng Zhang, Susanne Raulefs, Kuangyu Shi, Katja Steiger, Nadja Maeritz, Karin Kleigrewe, Thomas Hofmann, Simone Benitz et al. · 2018 · Cellular and Molecular Gastroenterology and Hepatology
- Dysregulation of the miR-148a–GLUT1 axis promotes the progression and chemoresistance of human intrahepatic cholangiocarcinomaPei Tiemin, Peng Xiao, lang Qingfu, Yan Wang, Xue Junlin, He Zhefeng, Zhao Ming, Liang Desen, Meng Qinghui · 2020 · Oncogenesis
- Specific activation of glycolytic enzyme enolase 2 in BRAF V600E‐mutated colorectal cancerRyohei Yukimoto, Naohiro Nishida, Tsuyoshi Hata, Shiki Fujino, Takayuki Ogino, Norikatsu Miyoshi, Hidekazu Takahashi, Mamoru Uemura, Taroh Satoh, Hirofumi Yamamoto et al. · 2021 · Cancer Science
- Facile synthesis of multifunctional pharmaceutical carbon dots for targeted bioimaging and chemotherapy of tumorsJiafeng Wan, Shiqing Xu, Jing Li, Mengliu Yu, Kai Zhang, Gang Wei, Zhiqiang Su · 2022 · Nanoscale
- Diverse antitumor effects of ascorbic acid on cancer cells and the tumor microenvironmentTakeru Maekawa, Toru Miyake, Masaji Tani, Shinji Üemoto · 2022 · Frontiers in Oncology
- Deregulated Metabolic Pathways in Ovarian Cancer: Cause and ConsequenceRoopak Murali, Vaishnavi Balasubramaniam, Satish Srinivas, Sandhya Sundaram, Ganesh Venkatraman, Sudha R. Warrier, Arun Dharmarajan, Rajesh Kumar Gandhirajan · 2023 · Metabolites
- Tumor bioenergetics: An emerging avenue for cancer metabolism targeted therapyHyun Jung Kee, Jae‐Ho Cheong · 2014 · BMB Reports
- A Case Report - Volatile Metabolomic Signature of Malignant Melanoma using Matching Skin as a ControlTatjana Abaffy, Mecker Geraldine Moller, Daniel D. Riemer, Clara Milikowski · 2011 · Journal of Cancer Science & Therapy
- Integration of Mitochondrial Targeting for Molecular Cancer TherapeuticsPhilippe Marchetti, Pierre Guerreschi, Laurent Mortier, Jérôme Kluza · 2015 · International Journal of Cell Biology
- The metabolism-immune axis in colorectal cancer: remodeling the tumor microenvironment through metabolite signalingShaofan Hu, Hui Heng, Fang Yang, Meng Wang, Guoxiang Liu, Yuancai Xiang, Hongming Miao · 2025 · Frontiers in Immunology
- Glutamine, Glucose and other Fuels for CancerMaría Victoria Ruiz-Pérez, Francisca Sánchez‐Jiménez, Francisco José Alonso, Juan Segura, Javier Márquez, Miguel Ángel Medina · 2014 · Current Pharmaceutical Design
- Strategy to targeting the immune resistance and novel therapy in colorectal cancerGang Wang, Junjie Wang, Rui Guan, Yan Sun, Feng Shi, Jiayan Zhang, Zimeng Li, Jing Gao, Xingli Fu · 2018 · Cancer Medicine
- Inhibitory ASIC2-mediated calcineurin/NFAT against colorectal cancer by triterpenoids extracted from Rhus chinensis MillGang Wang, Yu-Zhu Wang, Yang Yu, Junjie Wang · 2019 · Journal of Ethnopharmacology
- Moonlighting Metabolic Enzymes in Cancer: New Perspectives on the Redox CodeJingwen Jiang, Liyuan Peng, Kui Wang, Canhua Huang · 2020 · Antioxidants and Redox Signaling
- Another Consequence of the Warburg Effect? Metabolic Regulation of Na+/H+ Exchangers May Link Aerobic Glycolysis to Cell GrowthEivind Salmorin Birkeland, Lisa Maria Koch, Reinhard Christoph Dechant · 2020 · Frontiers in Oncology
- Restricting Glutamine Uptake Enhances NSCLC Sensitivity to Third-Generation EGFR-TKI AlmonertinibYaming Liu, Xianming Ge, Jinlong Pang, Yuhan Zhang, Hao Zhang, Hongyan Wu, Fangtian Fan, Hao Liu · 2021 · Frontiers in Pharmacology
- The Ubiquitin–Proteasome System in Tumor MetabolismJie Wang, Yuandi Xiang, Mengqi Fan, Shizhen Fang, Qingquan Hua · 2023 · Cancers
- Ca 2+ -dependent demethylation of phosphatase PP2Ac promotes glucose deprivation–induced cell death independently of inhibiting glycolysisHa Yin Lee, Yoko Itahana, Stefan Schüchner, Masahiro Fukuda, Hyunsoo Shawn Je, Egon Ogris, David M. Virshup, Koji Itahana · 2018 · Science Signaling
- Mitochondrial dysfunction and effect of antiglycolytic bromopyruvic acid in GL15 glioblastoma cellsLara Macchioni, Magdalena Davidescu, Miriam Sciaccaluga, Cristina Marchetti, Graziella Migliorati, Stefano Coaccioli, Rita Roberti, Lanfranco Corazzi, Emilia Castigli · 2011 · Journal of Bioenergetics and Biomembranes
- Cancer cell metabolism, epigenetics and the potenti al influence of dietary components - A perspective.Clarissa Gerhäuser · 2012
- Adrenomedullin is a therapeutic target in colorectal cancerLiangjing Wang, Manish K. Gala, Masayoshi Yamamoto, Maria Simona Pino, Hirotoshi Kikuchi, Daniel S. Shue, Senji Shirasawa, Thomas R. Austin, Maureen P. Lynch, Bo R. Rueda et al. · 2013 · International Journal of Cancer
- A β-Camera Integrated with a Microfluidic Chip for Radioassays Based on Real-Time Imaging of Glycolysis in Small Cell PopulationsNam T. Vu, Zeta Tak For Yu, Begonya Comin-Anduix, Jonas Nørskov Søndergaard, Robert W. Silverman, Canny Y. N. Chang, Antoni Ribas, Hsian‐Rong Tseng, Arion F. Chatziioannou · 2011 · Journal of Nuclear Medicine
- KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancerHiroaki Niitsu, Takao Hinoi, Y Kawaguchi, Kazuhiro Sentani, Ryo Yuge, Yasuhiko Kitadai, Yusuke Sotomaru, T Adachi, Yasufumi Saito, Masashi Miguchi et al. · 2016 · Oncogenesis
- Caring for cells in microsystems: principles and practices of cell-safe device design and operationSarvesh Varma, Joel Voldman B · 2018 · Lab on a Chip
- GLUT1/3/4 as novel biomarkers for the prognosis of human breast cancerKai Zeng, Gaoda Ju, Hao Wang, Jiang-Sheng Huang · 2020 · Translational Cancer Research
- Metabolic plasticity allows cancer cells to thrive under nutrient starvationWilhelm Palm · 2021 · Proceedings of the National Academy of Sciences
- Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironmentAdnan Moinuddin, Sophie M. Poznanski, Ana L. Portillo, Jonathan K. Monteiro, Ali A. Ashkar · 2024 · Immunological Reviews
- Emerging Trends in Gastrointestinal Cancer Targeted Therapies: Harnessing Tumor Microenvironment, Immune Factors, and Metabolomics InsightsSanchita Rauth, Mokenge Peter Malafa, Moorthy Palanimuthu Ponnusamy, Surinder K. Batra · 2024 · Gastroenterology
- Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer CellsKoichi Okamoto, Aziz Zaanan, Hisato Kawakami, Shengbing Huang, Frank A. Sinicrope · 2014 · Molecular Cancer Research
- The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routesMagdalena Davidescu, Lara Macchioni, Gaetano Scaramozzino, Maria Cristina Marchetti, Graziella Migliorati, Rita Vitale, Angela Corcelli, Rita Roberti, Emilia Castigli, Lanfranco Corazzi · 2015 · Scientific Reports
- Does nutrition for cancer patients feed the tumour? A clinical perspectiveFederico Bozzetti, Zeno Giovanni Stanga · 2020 · Critical Reviews in Oncology/Hematology
- Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysisSnehangshu Kundu, Muhammad Akhtar Ali, Niklas Handin, Louis Patrick Conway, Verónica Rendo, Per Artursson, Liqun He, Daniel Globisch, Tobias Sjöblom · 2021 · Journal of Experimental & Clinical Cancer Research
- The BRAF V600E Mutation in Papillary Thyroid Carcinoma Is Associated with Glucose Transporter 1 OverexpressionFlorian Grabellus, Karl Worm, Kurt Werner Schmid, Sien‐Yi Sheu · 2011 · Thyroid
- Fetal Bovine SerumMary Johnson · 2012 · Materials and Methods
- miR-27a promotes proliferation, migration, and invasion of colorectal cancer by targeting FAM172A and acts as a diagnostic and prognostic biomarkerWenjun Liu, Kai Qian, Xing Wei, Haijun Deng, Bei Zhao, Qing Chen, Jinqian Zhang, Hao Liu · 2017 · Oncology Reports
- The Sweet Surrender: How Myeloid Cell Metabolic Plasticity Shapes the Tumor MicroenvironmentJe Lin Sieow, Sin Yee Gun, Siew Cheng Wong · 2018 · Frontiers in Cell and Developmental Biology
- Metabolic implication of tumor:stroma crosstalk in breast cancerAndrea Morandi, Paola Chiarugi · 2014 · Journal of Molecular Medicine
- Glutamate dehydrogenase 1 mediated glutaminolysis sustains HCC cells survival under glucose deprivationYu-Jiao Zhou, Haibo Yu, Sheng‐Tao Cheng, Yao Chen, Lin He, Ji‐Hua Ren, Xin Qi He, Juan Chen, Lu Zheng, Fan Li et al. · 2022 · Journal of Cancer
- 18[F]FDG-PET/CT is a Useful Molecular Marker in Evaluating Tumour Aggressiveness: A Revised Understanding of an In-Vivo FDG-PET Imaging that Alludes the Alteration of Cancer BiologyF. Fathinul, Abdul Jalil Nordin, Eddie W. F. Lau · 2012 · Cell Biochemistry and Biophysics
- Prognostic biomarkers in colorectal cancer: where do we stand?Xavier Sagaert · 2014 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
- PPARα Promotes Cancer Cell Glut1 Transcription RepressionMengli You, Jianhua Jin, Qian Liu, Qinggang Xu, Juanjuan Shi, Yongzhong Hou · 2016 · Journal of Cellular Biochemistry
- A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximabSang Gyu Lee, Yong‐Hee Cho, Pu-Hyeon Cha, Jeong-Soo Yoon, Eun Ji Ro, Woo-Jeong Jeong, Jieun Park, Hyuntae Kim, Tae Il Kim, Do Sik Min et al. · 2018 · Experimental & Molecular Medicine
- Knockout of Dual-Specificity Protein Phosphatase 5 Protects Against Hypertension-Induced Renal InjuryChao Zhang, Xiaochen He, Sydney Murphy, Huawei Zhang, Shaoxun Wang, Ying Chun Ge, Wen‐Jun Gao, Jan Michael Williams, Aron M. Geurts, Richard J. Roman et al. · 2019 · Journal of Pharmacology and Experimental Therapeutics
- AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancerYe, Hua, Liu, Yi, Wu, Kefeng, Luo, Hui, Cui, Liao · 2020 · Cell Communication and Signaling
- GLUT1 inhibition by BAY-876 induces metabolic changes and cell death in human colorectal cancer cellsMasato Hayashi, Keishi Nakamura, Shinichi Harada, Mariko Hori Tanaka, Akiko Kobayashi, Hiroto Saito, Toshikatsu Tsuji, Daisuke Yamamoto, Hideki Moriyama, Jun Kinoshita et al. · 2025 · BMC Cancer
- Elucidating tumor-stromal metabolic crosstalk in colorectal cancer through integration of constraint-based models and LC-MS metabolomicsJunmin Wang, Alireza Delfarah, Patrick E. Gelbach, Emma J. Fong, Paul Macklin, Shannon M. Mumenthaler, Nicholas Alexander Graham, Stacey D. Finley · 2021 · Metabolic Engineering
- Noninvasive and Highly Selective Monitoring of Intracellular Glucose via a Two-Step Recognition-Based NanokitJianru Tang, Dandan Ma, Stevan Pecic, Caixia Huang, Jing Zheng, Jishan Li, Ronghua Yang · 2017 · Analytical Chemistry
- Metabolic rewiring drives resistance to targeted cancer therapyJason W. Locasale · 2012 · Molecular Systems Biology
- Metabolic Biomarker–Based BRAFV600 Mutation Association and Prediction in MelanomaHanna Saadani, Bernies van der Hiel, Else A. Aalbersberg, Ioannis Zavrakidis, John B.A.G. Haanen, Otto S. Hoekstra, Ronald Boellaard, Marcel P. M. Stokkel · 2019 · Journal of Nuclear Medicine
- Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung CancerSuhu Liu, Helen I. Gandler, Isidora Tošić, Darwin Q. Ye, Zachary T. Giaccone, David A. Frank · 2021 · Molecular Cancer Research
- Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung CancersElona Cekani, Samantha Epistolio, Giulia Dazio, Marco Cefalì, Luciano Wannesson, Milo Frattini, Patrizia Froesch · 2022 · Cancers
- The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancerWakkas Fadhil, Salih Ibrahem, Rashmi Seth, Ghada AbuAli, Krishna Ragunath, Philip Kaye, Mohammad Ilyas · 2012 · Histopathology
- Bioactive Food Components and Cancer‐Specific Metabonomic ProfilesYoung Shin Kim, John A. Milner · 2010 · BioMed Research International
- Annual fasting plasma glucose variation increases risk of cancer incidence and mortality in patients with type 2 diabetes: the Taichung Diabetes StudyCheng‐Chieh Lin, Chia-Ing Li, Chiu-Shong Liu, Wen‐Yuan Lin, Ching‐Chu Chen, Sing-Yu Yang, Cheng-Chun Lee, Tsai‐Chung Li · 2012 · Endocrine Related Cancer
- A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolismWensheng Liu, Bo Zhang, Qiangsheng Hu, Yi Qin, Wenyan Xu, Si Shi, Chen Liang, Qingcai Meng, Jinfeng Xiang, Dingkong Liang et al. · 2017 · International Journal of Oncology
- Energy stress-induced circZFR enhances oxidative phosphorylation in lung adenocarcinoma via regulating alternative splicingZhifei Ma, Hao Chen, Zhijun Xia, Jing You, Chencheng Han, Siwei Wang, Wenjia Xia, Yongkang Bai, Tongyan Liu, Lin Xu et al. · 2023 · Journal of Experimental & Clinical Cancer Research
- Autophagy sustains mitochondrial respiration and determines resistance to BRAF V600E inhibition in thyroid carcinoma cellsSergio Díaz Gago, Javier Vicente-Gutiérrez, Jose Manuel Ruiz-Rodríguez, Josep Calafell-Segura, Alicia Álvarez-Álvarez, Marina Lasa, Antonio Chiloeches, Pablo Baquero · 2024 · Autophagy
- DR4-Ser424O-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to DeathHyeon-Jeong Lee, Yumin Oh, Young-Jun Jeon, Song-Yi Lee, Hyun‐Joo Kim, Ho-June Lee, Yong‐Keun Jung · 2019 · Cancer Research
- Metabolic switch in cancer – Survival of the fittestHans Raskov, Shruti Gaggar, Asma Tajik, Adile Orhan, Ismail Gögenür · 2022 · European Journal of Cancer
- Cancer plasticity: Investigating the causes for this agilityShubhraneel Saha, Nikita Pradhan, B Neha, Ravikiran Mahadevappa, Shilpi Minocha, Saran Kumar · 2022 · Seminars in Cancer Biology
- Energy metabolism and proliferation in pancreatic carcinogenesisI. Regel, B. Kong, S. Raulefs, M. Erkan, C. Michalski, M. Hartel, J. Kleeff · 2012 · Langenbeck's archives of surgery (Print)
- Metabolic effects of antiangiogenic drugs in tumors: Therapeutic implicationsLuigi Quintieri, Mohamed Selmy, Stefano Indraccolo · 2014 · Biochemical Pharmacology
- Maltotriose Conjugation to a Chlorin Derivative Enhances the Antitumor Effects of Photodynamic Therapy in Peritoneal Dissemination of Pancreatic CancerAkihisa Kato, Hiromi Kataoka, Shigenobu Yano, Kazuki Hayashi, Noriyuki Hayashi, Mamoru Tanaka, Itaru Naitoh, Tesshin Ban, Katsuyuki Miyabe, Hiromu Kondo et al. · 2017 · Molecular Cancer Therapeutics
- Genome-wide Analysis Reveals DNA Methylation Alterations in Obesity Associated with High Risk of Colorectal CancerLixin Dong, Li Ma, Gloria H. Ma, Hongmei Ren · 2019 · Scientific Reports
- Perspective: Do Fasting, Caloric Restriction, and Diets Increase Sensitivity to Radiotherapy? A Literature ReviewPhilippe Icard, Luc Ollivier, Patricia Forgez, Joëlle Otz, Marco Alifano, Ludovic Fournel, Mauro Loi, Juliette Thariat · 2020 · Advances in Nutrition
- AMPKα loss promotes KRAS-mediated lung tumorigenesisManuela La Montagna, Lei Shi, Peter Magee, Sudhakar Sahoo, Matteo Fassan, Michela Garofalo · 2021 · Cell Death and Differentiation
- Mitochondrial Respiration in KRAS and BRAF Mutated Colorectal Tumors and PolypsEgle Rebane-Klemm, Laura Truu, Leenu Reinsalu, Marju Puurand, Igor N. Shevchuk, Vladimir A. Chekulayev, Natalja Timohhina, Kersti Tepp, Jelena Bogovskaja, Vladimir Afanasjev et al. · 2020 · Cancers
- BRAF activation by metabolic stress promotes glycolysis sensitizing NRASQ61-mutated melanomas to targeted therapyKimberley McGrail, Paula Granado‐Martínez, Rosaura Esteve‐Puig, Sara García-Ortega, Yuxin Ding, Sara Sánchez‐Redondo, Berta Ferrer Fábrega, Javier Hernández‐Losa, Françesc Canals, Ànna Manzano et al. · 2022 · Nature Communications
- The α-Arrestin Bul1p Mediates Lactate Transporter Endocytosis in Response to Alkalinization and Distinct Physiological SignalsGabriel Talaia, Christos Gournas, Elie Saliba, Cláudia Barata-Antunes, Margarida Casal, Bruno André, George Diallinas, Sandra Paiva · 2017 · Journal of Molecular Biology
- The importance of BRAF‐V600E mutation to ameloblastoma metabolismFilipe Fideles Duarte‐Andrade, André Myller Barbosa Silva, Jéssica Gardone Vitório, Gisele André Baptista Canuto, Sara Ferreira dos Santos Costa, Marina Gonçalves Diniz, Ana Paula Fernandes, Juliano Simões de Toledo, Leiliane Coelho André, Carolina Cavaliéri Gomes et al. · 2019 · Journal of Oral Pathology and Medicine
- Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cellsJiajun Ding, Qian Gou, Jianhua Jin, Juanjuan Shi, Qian Liu, Yongzhong Hou · 2019 · European Journal of Pharmacology
- Dual Inhibition of GLUT1 and the ATR/CHK1 Kinase Axis Displays Synergistic Cytotoxicity in KRAS -Mutant Cancer CellsJohanna Erber, Joachim David Steiner, Jörg Isensee, Leonard A. Lobbes, André Toschka, Filippo Beleggia, Anna Schmitt, Rainer W. J. Kaiser, Florian Siedek, Thorsten Persigehl et al. · 2019 · Cancer Research
- Vacuolar H+-ATPase Subunit V0C Regulates Aerobic Glycolysis of Esophageal Cancer Cells via PKM2 SignalingSung Wook Son, Gia Cac Chau, Seong‐Tae Kim, Sung Hee Um · 2019 · Cells
- Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stressChristian Marx, Jürgen Sonnemann, Oliver D.K. Maddocks, Lisa Marx-Blümel, Mandy Beyer, Doerte Hoelzer, René Thierbach, Claudia Maletzki, Michael Linnebacher, Thorsten Heinzel et al. · 2022 · Cancer & Metabolism